Literature DB >> 27889841

The function of activatable cell-penetrating peptides in human intrahepatic bile duct epithelial cells.

Kui Tu1, Lijin Zhao2, Jin Gu1, Pengzhan Yan1, Fang Wang1, Yu Cao1.   

Abstract

This study aimed to investigate the function of Activatable Cell-Penetrating Peptides (ACPP) in detecting the changes of human intrahepatic bile duct epithelial cell(hIBDEC). ACPP, which target matrix metalloproteinases, were constructed. All were labeled with FITC and Gd-DTPA at the N-terminal. Fluorescence microscopy was used to observe the fluorescence intensity inside hIBDEC after stimulating with different concentrations of LPS and incubating with different concentrations of ACPP to determine the optimal concentration range for LPS stimulation and the optimal concentration for FITC-ACPP effect. Flow cytometry and magnetic resonance imaging were used to detect fluorescence signal intensity and nuclear magnetic resonance signal intensity, respectively, after stimulating with different concentrations of LPS. LPS stimulation time and ACPP incubation time were also evaluated, and variance analysis was conducted to analyze intracellular signal change characteristics for every group. Activatable Cell-Penetrating Peptides (ACPP), which were marked with FITC and Gd-DTPA had target-penetrating activity. The intracellular signal intensity gradually increased with the increase in LPS stimulation time and ACPP incubation time within a certain range; however, it did not increase with the increase of LPS concentration. ACPP can be used for imaging hIBDEC with epithelial-mesenchymal transition.

Entities:  

Keywords:  Activable cell-penetrating peptide; Epithelial–mesenchymal transition; Human intrahepatic bile duct epithelial cell; Lipopolysaccharide; Molecular imaging

Mesh:

Substances:

Year:  2016        PMID: 27889841     DOI: 10.1007/s10863-016-9690-8

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  17 in total

1.  Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide.

Authors:  Maria Lindgren; Katri Rosenthal-Aizman; Külliki Saar; Emelía Eiríksdóttir; Yang Jiang; Meeri Sassian; Pernilla Ostlund; Mattias Hällbrink; Ulo Langel
Journal:  Biochem Pharmacol       Date:  2006-01-10       Impact factor: 5.858

2.  A novel approach using functional peptides for efficient intestinal absorption of insulin.

Authors:  Mariko Morishita; Noriyasu Kamei; Jumpei Ehara; Koichi Isowa; Kozo Takayama
Journal:  J Control Release       Date:  2006-12-29       Impact factor: 9.776

3.  The pathobiology of biliary epithelia.

Authors:  S K Roberts; J Ludwig; N F Larusso
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

4.  T cell-mediated biliary epithelial-to-mesenchymal transition in liver allograft rejection.

Authors:  Karolina A Rygiel; Helen Robertson; Joseph D P Willet; John G Brain; Alastair D Burt; David E J Jones; John A Kirby
Journal:  Liver Transpl       Date:  2010-05       Impact factor: 5.799

5.  Novel dinucleotide repeat polymorphism in the first exon of the STAT-6 gene is associated with allergic diseases.

Authors:  K Tamura; H Arakawa; M Suzuki; Y Kobayashi; H Mochizuki; M Kato; K Tokuyama; A Morikawa
Journal:  Clin Exp Allergy       Date:  2001-10       Impact factor: 5.018

6.  LPS-induced epithelial-mesenchymal transition of intrahepatic biliary epithelial cells.

Authors:  Lijin Zhao; Rigao Yang; Long Cheng; Maijian Wang; Yan Jiang; Shuguang Wang
Journal:  J Surg Res       Date:  2010-05-26       Impact factor: 2.192

7.  Design and Synthesis of New Cell Penetrating Peptides: Diffusion and Distribution Inside the Cornea.

Authors:  Silvia Pescina; Marina Sala; Cristina Padula; Maria Carmina Scala; Antonia Spensiero; Silvana Belletti; Rita Gatti; Ettore Novellino; Pietro Campiglia; Patrizia Santi; Sara Nicoli; Carmine Ostacolo
Journal:  Mol Pharm       Date:  2016-10-04       Impact factor: 4.939

8.  MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.

Authors:  Jia-Yuan Huang; Kai Zhang; Dong-Qin Chen; Jing Chen; Bing Feng; Haizhu Song; Yitian Chen; Ziman Zhu; Lei Lu; Wei De; Rui Wang; Long-Bang Chen
Journal:  Oncotarget       Date:  2015-07-30

9.  Tat-mediated delivery of heterologous proteins into cells.

Authors:  S Fawell; J Seery; Y Daikh; C Moore; L L Chen; B Pepinsky; J Barsoum
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 12.779

Review 10.  MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment.

Authors:  Maria Jose Lorenzo Pisarello; Lorena Loarca; Tommy Ivanics; Leslie Morton; Nicholas LaRusso
Journal:  J Clin Med       Date:  2015-08-26       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.